Predictors of In-Hospital Mortality in ST-Segment Elevation Myocardial Infarction: A Prospective Multicenter Cohort from a Conflict-Affected, Resource-Limited Setting
In a prospective multicenter cohort of 920 STEMI patients in conflict-affected Yemen, in-hospital mortality was independently predicted by baseline cardiovascular vulnerability and hemodynamic compromise rather than total ischemic time, while beta-blockers and SGLT2 inhibitors demonstrated strong protective effects.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Heart attacks are a race against time. When a major artery feeding the heart muscle becomes blocked, the tissue downstream begins to die. The speed at which doctors can restore blood flow determines how much heart muscle is saved and whether a patient survives. In wealthy nations, this race is often won by specialized emergency teams that rush patients directly to catheterization labs for immediate surgery. But in places where conflict has shattered hospitals, disrupted supply chains, and scattered medical staff, the rules of the game change. Patients arrive later, often sicker, and with fewer resources to treat them. Understanding who survives in these fragile environments, and why, is not just an academic exercise; it is a matter of life and death for millions living in regions where the healthcare system is barely holding together.
A team of researchers set out to solve this puzzle in Yemen, a country where years of war have left the healthcare system in a state of crisis. They followed 920 consecutive patients who arrived at seven different cardiac centers across the country with a specific, severe type of heart attack known as ST-segment elevation myocardial infarction. This is the kind of heart attack where the blockage is complete and the heart muscle is under immediate threat. The researchers wanted to know what factors predicted whether a patient would survive their hospital stay. They looked at everything from the patient's age and medical history to how long they waited for treatment and what medications they received. The goal was to separate the signals that truly matter from the noise, creating a clear picture of risk in a setting where standard medical rules might not apply.
The study found that the most powerful predictor of survival was not how long a patient waited in the ambulance, but the condition of their heart and body the moment they walked through the hospital doors. Patients who had suffered a heart attack before were more than five times as likely to die during this hospital stay compared to those with no prior history. This suggests that a heart already weakened by past damage has very little reserve left to withstand a new crisis. Similarly, patients who arrived with signs of heart failure, such as fluid in the lungs or low blood pressure, faced significantly higher risks. The researchers also found that patients with higher levels of creatinine in their blood—a marker indicating the kidneys were struggling—and those with lower pumping power in their heart muscle were far more likely to die. These findings highlight that in a broken system, the patient's baseline vulnerability matters more than the speed of the hospital's response.
One of the most striking discoveries was a phenomenon often called the "smoker's paradox." In this group of patients, those who smoked were actually less likely to die than those who did not. This seems to contradict everything known about the dangers of tobacco. However, the researchers explained that this was not because smoking was helpful. Instead, the smokers in this study were a different group of people: they were significantly younger and had fewer other health problems like high blood pressure or diabetes. They arrived at the hospital with stronger hearts and better blood pressure than the non-smokers. The apparent survival advantage was simply a reflection of their youth and better overall health, not a benefit of the cigarette.
The study also shed light on the treatments that worked best in this difficult environment. Patients who received beta-blockers, a common medication that slows the heart rate and reduces its workload, were much more likely to survive. Another class of drugs, known as SGLT2 inhibitors, which are typically used for diabetes, also showed a strong protective effect, with patients taking them having a much lower chance of dying. These medications appear to act as a vital safety net, helping the heart cope with the stress of the attack when advanced surgical options are delayed or unavailable.
Interestingly, the length of time it took for a patient to get to the hospital did not independently predict death in the final analysis. While it is always better to arrive sooner, the data showed that once a patient reached the hospital, their fate was largely sealed by the severity of their condition upon arrival. The researchers noted that in a conflict zone, the patients who suffered the most catastrophic heart attacks often died before they could reach a hospital at all. Those who made it to the hospital were a selected group, and for them, the quality of their heart function and the presence of other organ failures were the deciding factors.
The study concludes that in healthcare systems fractured by conflict, the short-term outlook for a heart attack patient is determined primarily by how vulnerable their body was before the event and how much strain their heart was under when they arrived. While the chaos of war inevitably causes delays, the most critical steps for saving lives lie in recognizing these high-risk patients immediately and using available medications to support the heart. By focusing on the patient's immediate physiological state rather than just the clock, doctors in these fragile settings can better identify who needs the most urgent care and improve the chances of survival for a population that has very little margin for error.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.